Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-04-08, Stock:LLY, The news for the past five days is as follows:
2020-04-01: NEWS1: Pharma Giant Eli Lilly (LLY) Stock is a Buy During the Coronavirus Economy.NEWS2: Merck, Pfizer, Eli Lilly launch worker volunteer programs to aid in coronavirus fight.NEWS3: Medical Professionals Across Merck & Co., Inc., Pfizer Inc., and Eli Lilly and Company Activate to Support Health Systems, First Responders and Patients Amid COVID-19 Pandemic.NEWS4: Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?.NEWS5: 3 Drugmakers Still Worth Betting on Amid Coronavirus Woes.NEWS6: Is There An Opportunity With Eli Lilly and Company's (NYSE:LLY) 25% Undervaluation?.
2020-04-02: NEWS1: Stock Indexes Jump As Jobless Claims Soar Again.NEWS2: LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day.NEWS3: Top Analyst Reports for Eli Lilly, Charter Communications & Eaton.NEWS4: Here's Why You Should Buy Lilly Stock Amid Coronavirus Crisis.NEWS5: Eli Lilly Shows Relative Strength.NEWS6: Healthcare stocks show their defensive allure in ailing market.NEWS7: Bull of the Day: Eli Lilly (LLY).
2020-04-03: NEWS1: IBD Stock Of The Day: Why Eli Lilly Is Outplaying Its Pharma Giant Peers.NEWS2: The Zacks Analyst Blog Highlights: Eli Lilly, Charter, Eaton, Autodesk and Cypress Semiconductor.NEWS3: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS4: Pharma Stock Roundup: JNJ & SNY's Coronavirus Product Development, Other Updates.
2020-04-06: NEWS1: Alnylam, Dicerna Join Forces to Take on Arrowhead.NEWS2: Another Drug to Fight Coronavirus & 3 Picks.NEWS3: Why the Earnings Surprise Streak Could Continue for Lilly (LLY).NEWS4: The Zacks Analyst Blog Highlights: J&J, Sanofi, AstraZeneca, Lilly and Merck.
2020-04-07: NEWS1: Eli Lilly Lowers Insulin Cost in Response to Coronavirus Pandemic.NEWS2: Eli Lilly and Company to Hold 2020 Annual Meeting of Shareholders Virtually.NEWS3: The Zacks Analyst Blog Highlights: Eli Lilly, Qualcomm and Electronic Arts.NEWS4: Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day.NEWS5: Eli Lilly offers new $35 co-pay insulin value program during coronavirus pandemic.NEWS6: Eli Lilly lowers insulin costs as coronavirus crisis deepens.NEWS7: New $35 Co-Pay Now Available Through Lilly Insulin Value Program in Response to COVID-19 Crisis in U.S..

Answer: Rise